Newborn screening for cystic fibrosis: the motion against - voices in the wilderness

Paediatric Respiratory Reviews

Volumn 9, Issue 4, 2008, Pages 295-300

  Rosenthal, Mark ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

CF screening; Scepticism

Indexed keywords

ALPHA TOCOPHEROL;

CLINICAL TRIAL; COST BENEFIT ANALYSIS; CYSTIC FIBROSIS; DELAYED DIAGNOSIS; DIAGNOSTIC APPROACH ROUTE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MUTATIONAL ANALYSIS; NEWBORN; NEWBORN SCREENING; NORMAL VALUE; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; REVIEW; SENSITIVITY AND SPECIFICITY; SWEAT TEST;

COST-BENEFIT ANALYSIS; CYSTIC FIBROSIS; HUMANS; INFANT, NEWBORN; MASS SCREENING;

EID: 56049101602     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2008.09.003     Document Type: Review

References (11)

1. McCormick J., Sims E.J., Green M.W., Mehta G., Culross F., and Mehta A. Comparative analysis of cystic fibrosis registry data from the UK with USA, France and Australasia. J Cyst Fibros 4 (2005) 115-122
2. Farrell P.M., Kosorok M.R., Laxova A., et al. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med 337 (1997) 963-969
3. Farrell P.M., Kosorok M.R., Rock M.J., et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 107 (2001) 1-13
4. Wald N.J., and Morris J.K. Neonatal screening for cystic fibrosis. BMJ 316 (1998) 404-405
5. Farrell P.M., Li Z., Kosorok M.R., et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med 168 (2003) 1100-1108
6. Koscik R.L., Farrell P.M., Kosorok M.R., et al. Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition. Pediatrics 113 (2004) 1549-1558
7. Doull I.J., Ryley H.C., Weller P., and Goodchild M.C. Cystic fibrosis-related deaths in infancy and the effect of newborn screening. Pediatr Pulmonol 31 (2001) 363-366
8. Grosse S.D., Rosenfeld M., Devine O.J., Lai H.J., and Farrell P.M. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. J Pediatr 149 (2006) 362-366
9. Siret D., Bretaudeau G., Branger B., et al. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol 35 (2003) 342-349
10. McKay K.O., Waters D.L., and Gaskin K.J. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in New South Wales. J Pediatr 147 3 Suppl (2005) S47-S50
11. Sims E.J., Mugford M., Clark A., et al. UK Cystic Fibrosis Database Steering Committee. Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study. Lancet 369 (2007) 1187-1195 Erratum in: Lancet 2007; 370: 28.